← Dashboard
Oct 12, 2026 08:20 PM ET
Signal
Corporate
Nurix Therapeutics GAAP EPS of $4.73 beats by $1.64, revenue of $673.1M beats by $193.58M
Nurix Therapeutics EPS beat by $1.64 and revenue beat by $193.58M.
What changed
Nurix Therapeutics EPS beat by $1.64 and revenue beat by $193.58M.
Why it matters
Nurix Therapeutics EPS beat by $1.64 and revenue beat by $193.58M. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →